Case Study: Genmab accelerates antibody discovery with IDBS ActivityBase XE

Genmab - Customer Case Study

Genmab, a biopharmaceutical company using unique antibody technology to target disease-related antigens, needed a flexible way to capture, validate, and visualize screening data for monoclonal antibody-based products across cancer, infectious diseases, rheumatoid arthritis, and other inflammatory conditions. The company also needed to manage plate-based serum, primary and secondary screening assays, and support trend analysis and graphical reporting to identify disease targets that could be reproduced at scale. IDBS provided ActivityBase XE to address these discovery-data challenges.

With IDBS’ ActivityBase XE, Genmab can capture and store screening data in one accessible location, making results transparent and available for reference and further analysis at any stage. The solution’s trend analysis, visualization, and curve-fitting capabilities help scientists identify patterns, determine screen quality, select hits, and calculate IC50/EC50 values more efficiently and with less error, improving accuracy, workflow efficiency, and speeding up results generation.

Genmab